Skip to main content
EXAGEN INC. logo

EXAGEN INC. — Investor Relations & Filings

Ticker · XGN ISIN · US30068X1037 LEI · 549300JV2CYDOME5OO17 US Human health and social work activities
Filings indexed 397 across all filing types
Latest filing 2026-05-12 Registration Form
Country US United States of America
Listing US XGN

About EXAGEN INC.

https://exagen.com/

Exagen Inc. is a commercial-stage life sciences company focused on transforming the care continuum for patients with complex autoimmune diseases. Operating as a rheumatology specialty laboratory, the company develops and provides advanced testing solutions for the diagnosis, prognosis, and monitoring of these conditions. Its core offering is the AVISE® testing portfolio, which leverages proprietary biomarker technology to provide physicians with critical insights for timely and accurate differential diagnosis. These tools are designed to empower healthcare providers, particularly rheumatologists, in managing debilitating chronic diseases such as lupus and rheumatoid arthritis, ultimately aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
S-8 - EXAGEN INC. (0001274737) (Filer)
Registration Form
2026-05-12 English
10-Q - EXAGEN INC. (0001274737) (Filer)
Interim / Quarterly Report
2026-05-11 English
8-K - EXAGEN INC. (0001274737) (Filer)
Regulatory Filings
2026-05-11 English
ARS - EXAGEN INC. (0001274737) (Filer)
Annual Report
2026-04-27 English
DEF 14A - EXAGEN INC. (0001274737) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English
8-K - EXAGEN INC. (0001274737) (Filer)
Regulatory Filings
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.